Veit J Erpenbeck Selected Research

prostaglandin D2 receptor

10/2021	Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
1/2021	The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism.
9/2018	The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
1/2017	Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veit J Erpenbeck Research Topics

Disease

21	Asthma (Bronchial Asthma) 10/2021 - 06/2003
8	Inflammation (Inflammations) 01/2021 - 03/2004
2	Chronic Urticaria 01/2019 - 01/2017
2	Body Weight (Weight, Body) 09/2014 - 01/2013
1	Infections 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2011
1	Disease Progression 03/2011
1	Airway Obstruction (Choking) 03/2011
1	Surfactant Dysfunction 03/2004

Drug/Important Bio-Agent (IBA)

7	AllergensIBA 01/2013 - 06/2003
5	Omalizumab (Xolair)FDA Link 01/2019 - 01/2013
5	Immunoglobulin E (IgE)IBA 12/2016 - 11/2005
5	Surface-Active Agents (Surfactants)IBA 03/2009 - 03/2004
4	prostaglandin D2 receptorIBA 10/2021 - 01/2017
4	fevipiprantIBA 01/2021 - 01/2016
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2014
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 03/2011 - 04/2005
2	Prostaglandin D2IBA 10/2021 - 09/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
2	CytokinesIBA 01/2020 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2011
2	anti-IgE antibodiesIBA 01/2019 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2016 - 09/2005
2	poractant alfa (Curosurf)FDA Link 01/2009 - 03/2004
2	salicylhydroxamic acid (SHAM)IBA 01/2006 - 06/2003
2	Pulmonary Surfactants (Pulmonary Surfactant)IBA 03/2004 - 03/2004
1	ProstaglandinsIBA 01/2021
1	LipidsIBA 09/2018
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	Pharmaceutical PreparationsIBA 11/2015
1	Therapeutic UsesIBA 03/2009
1	Transcription Factors (Transcription Factor)IBA 01/2006
1	NitratesIBA 09/2005
1	NitritesIBA 09/2005
1	Interleukin-6 (Interleukin 6)IBA 02/2005
1	Eosinophil Cationic ProteinIBA 03/2004
1	Interleukin-9 (Interleukin 9)IBA 06/2003

Therapy/Procedure

2	Therapeutics 01/2016 - 01/2009
1	Duration of Therapy 09/2014